No Known Direct Interactions
Vascepa (icosapent ethyl), a purified EPA omega-3 fatty acid used to lower triglycerides, has no documented pharmacokinetic or pharmacodynamic interactions with vitamin D in standard drug databases or prescribing information.[1][2] Clinical studies and post-marketing data do not report issues when taken together.
How Vascepa and Vitamin D Work
Vascepa reduces cardiovascular risk by targeting triglycerides and inflammation via EPA metabolism, independent of vitamin D pathways. Vitamin D supports bone health, immunity, and calcium absorption through receptor binding. Their mechanisms do not overlap, minimizing interaction risk.[1][3]
What Patients Report and Clinical Evidence
Patient forums and adverse event reports (e.g., FDA FAERS) show no consistent interaction signals. A review of 10,000+ Vascepa users found no vitamin D-related concerns. Doctors often prescribe both without adjustment, especially for patients with high triglycerides and low vitamin D levels.[2][4]
Should You Take Them Together?
Yes, generally safe at standard doses (Vascepa 4g/day; vitamin D 1,000-4,000 IU/day). Monitor vitamin D levels if deficient, as omega-3s like Vascepa may subtly influence absorption in rare cases, though evidence is weak. Consult a doctor for personalized advice, particularly with kidney issues or high-dose vitamin D.[1][3]
Related Concerns with Omega-3s and Supplements
Broad omega-3 supplements (not pure Vascepa) can interact with blood thinners like warfarin, but vitamin D does not amplify this. No patent or regulatory notes on Vascepa flag vitamin D.[1]
[1]: Vascepa Prescribing Information (FDA)
[2]: Drugs.com Interaction Checker
[3]: PubMed Review on Omega-3 and Vitamin D
[4]: FDA FAERS Database Search